ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesK74.01

K74.01

Billable

Hepatic fibrosis, early fibrosis

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/06/2025

Code Description

ICD-10 K74.01 is a billable code used to indicate a diagnosis of hepatic fibrosis, early fibrosis.

Key Diagnostic Point:

Hepatic fibrosis, early fibrosis, is a condition characterized by the accumulation of excess fibrous connective tissue in the liver, often as a response to chronic liver injury. This condition can arise from various etiologies, including chronic viral hepatitis, alcohol abuse, non-alcoholic fatty liver disease (NAFLD), and autoimmune liver diseases. Clinically, patients may be asymptomatic in the early stages, but as fibrosis progresses, they may experience symptoms such as fatigue, jaundice, and abdominal discomfort. The liver anatomy involved includes hepatocytes, portal tracts, and the hepatic vasculature, where the fibrotic changes primarily occur in the portal areas and can lead to portal hypertension if left untreated. Disease progression can vary significantly among individuals, influenced by the underlying cause and the presence of co-morbidities. Diagnostic considerations include liver function tests, imaging studies (such as ultrasound or MRI), and liver biopsy, which can confirm the presence and extent of fibrosis. Non-invasive methods like elastography are also increasingly used to assess liver stiffness as a surrogate marker for fibrosis.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Diagnostic complexity: Requires differentiation from other liver conditions.
  • Treatment complexity: Management may involve lifestyle changes, medications, or monitoring.
  • Documentation requirements: Detailed clinical history and diagnostic tests are necessary.
  • Coding specificity: Requires accurate coding to reflect the stage of fibrosis.

Audit Risk Factors

  • Common coding errors: Misclassification of fibrosis stage.
  • Documentation gaps: Lack of comprehensive clinical notes or diagnostic evidence.
  • Billing challenges: Potential denials due to insufficient documentation supporting the diagnosis.

Specialty Focus

Medical Specialties

Gastroenterology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Hepatology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related ICD-10 Codes

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

Hepatic fibrosis, particularly in its early stages, has significant clinical implications as it can progress to more severe liver disease, including cirrhosis and liver failure. Population health impact is notable, as liver diseases are a leading cause of morbidity and mortality worldwide. Early identification and management of hepatic fibrosis can improve patient outcomes, reduce healthcare utilization, and lower the burden on healthcare systems. Epidemiologically, conditions leading to hepatic fibrosis are prevalent, making awareness and proper coding essential for effective public health strategies.

ICD-9 vs ICD-10

Hepatic fibrosis, particularly in its early stages, has significant clinical implications as it can progress to more severe liver disease, including cirrhosis and liver failure. Population health impact is notable, as liver diseases are a leading cause of morbidity and mortality worldwide. Early identification and management of hepatic fibrosis can improve patient outcomes, reduce healthcare utilization, and lower the burden on healthcare systems. Epidemiologically, conditions leading to hepatic fibrosis are prevalent, making awareness and proper coding essential for effective public health strategies.

Reimbursement & Billing Impact

Reimbursement considerations include the need for clear evidence of the diagnosis, as well as the underlying cause of the hepatic fibrosis. Common denials may arise from insufficient documentation or failure to demonstrate medical necessity for diagnostic tests. Best practices include maintaining comprehensive clinical notes, ensuring that all relevant tests are documented, and using the most specific codes available to reflect the patient's condition accurately.

Resources

Clinical References

  • •
    ICD-10 Official Guidelines for K00-K99
  • •
    Clinical Documentation Requirements

Coding & Billing References

  • •
    ICD-10 Official Guidelines for K00-K99
  • •
    Clinical Documentation Requirements

Frequently Asked Questions

What specific conditions are covered by K74.01?

K74.01 specifically covers early hepatic fibrosis, which can result from chronic liver diseases such as hepatitis B and C, alcoholic liver disease, and NAFLD. It is essential to document the underlying cause of liver injury to support the diagnosis.

When should K74.01 be used instead of related codes?

K74.01 should be used when the patient is diagnosed with early hepatic fibrosis without significant progression to advanced fibrosis or cirrhosis. If there is evidence of more severe fibrosis, codes K74.02 or K74.03 should be considered.

What documentation supports K74.01?

Documentation should include a thorough clinical history, results from liver function tests, imaging studies, and, if applicable, liver biopsy results indicating the presence of early fibrosis. Regular monitoring and follow-up notes are also essential.